Abattis BioceuticalsATTBF
13F holders, Q1 2026 (March 31)1holders
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Abattis Bioceuticals Corp. (ATTBF) in their 13F filings, unchanged from Q2 2025. 1 opened new positions and 0 sold out. The largest holder was VSM Wealth Advisory, LLC ($0).
- Company
- Abattis Bioceuticals Corp.
- CUSIP
- 00258G103
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q1 2026: 1,200 shares bought, net +1,200 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| VSM Wealth Advisory, LLC | 0.00% | New | 1,200 | $0 |
"% of holder's portfolio" is ATTBF's weight in each manager's 13F, not the share of Abattis Bioceuticals Corp. the manager owns.